Category South Korea Gyeonggi-do Time range From July 1, 2014, to December 31, 2014 (184 days) Location range Latitude 33.203-38.575 [degrees] N 36.394-38.283 [degrees] N Longitude 125.287-129.576 [degrees] E 126.379-127.858 [degrees] E Number of 3,053 1,927 users Number of 4,257,430 1,998,935 observations Table 2: Comparison of weighted mean
values between the case using Gyeonggi-do data from users having 1,000 or more observations and applying a linear regression analysis by data source (AWS or smartphone) and the case using Gyeonggi-do data from users having 1,000 or more observations and applying a linear regression analysis with the additional classification into daytime and nighttime.
The following definitions can give the relationships between the non-Newtonian weighted means
and ordinary weighted means
Confidence interval and weighted means
of the effect size related to the Sub-hypotheses one to three Index of Marketing Index of Confidence Interval of Tactical Capabilities Performance the Effect Size Marketing Specialized Customer (0.083,0.312) Capabilities Performance Marketing Specialized Market (0.158,0.321) Capabilities Performance Marketing Specialized Financial (0.1,0.207) Capabilities Performance Index of Marketing Weighted Mean
of Tactical Capabilities the Effect Size Marketing Specialized 0.113 Capabilities Marketing Specialized 0.064 Capabilities Marketing Specialized 0.046 Capabilities Table 9.
The solid lines are the weighted mean
while the dashed lines are the standard mean.
All the weighted mean
effect sizes were negative and significantly different from 0.
diarrheal episodes/ child/y (75) 3.2 2.3 Total diarrheal episodes, x 1,000 251,306 650,252 901,559 At home (74,76) 221,651 597,583 819,234 At treatment facility (74,76) 29,655 52,670 82,325 In outpatient department 25,884 51,370 77,254 Hospitalized 3,771 1,300 5,071 Median caused by shigellosis, % At home * 4.4% In treatment facility ([dagger]) 5.8 9.4 Weighted mean
caused by shigellosis, % (95% confidence interval) 5.1 (4.0-5.7) No.
Conditions (i), (iv), and (v) of Theorem 1 are automatically satisfied for any weighted mean
difference (95% CI) between groups treated with a 0.1 mg/kg bolus of landiolol and placebo.
improvements of 19.2 on the pain scale of the foot function index, 19.4 on the index's activity limitation scale, and 18.6 on the disability scale were reported.
In the seven trials that included scores for the IIEF erectile function domain, the weighted mean
difference at the end of the study period was 6.6, in favor of the intervention group.
Effect sizes were grouped according to attitudinal factor and each group was statistically analyzed including a test for homogeneity, calculation of a weighted mean
effect size, and a 95% confidence interval.